Weight Management: A Guide for Employers
It seems every website, magazine, and media outlet is publishing article after article about new weight loss drugs like Ozempic and Mounjaro. This new generation of weight loss medication belongs to a class of drugs called GLP-1 receptor agonists. It’s no surprise that alongside media attention, employers and health plans are evaluating whether to include GLP-1s in their formularies. There are two competing priorities: the undeniable need for obesity treatment and the need to contain costs.
White Paper from 
If your Download does not start Automatically, Click Download Whitepaper